Bengaluru, India

Kiran K Jadhav

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kiran K Jadhav: Innovator in Pharmaceutical Composition

Introduction

Kiran K Jadhav is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 2 patents to his name, Jadhav is recognized for his expertise and dedication to advancing medical technology.

Latest Patents

Jadhav's latest patents focus on a pharmaceutical liposomal composition for docetaxel injection. The invention comprises a formulation that includes about 0.8% w/w to about 1% w/w of docetaxel, approximately 30% w/w to about 38% w/w of Soya Phosphatidyl Choline, and about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate. Additionally, the composition contains about 61% w/w to about 68% w/w of Sucrose and a pH adjusting agent, with the pH of the liposomal composition being less than 3.5. This innovative approach aims to enhance drug loading and improve therapeutic efficacy.

Career Highlights

Kiran K Jadhav is currently associated with Shilpa Medicare Limited, where he continues to work on groundbreaking pharmaceutical innovations. His role at the company allows him to collaborate with other talented professionals in the industry, contributing to the advancement of healthcare solutions.

Collaborations

Jadhav has worked alongside colleagues such as Prashanth S and Shivakumar Pradeep, fostering a collaborative environment that encourages innovation and creativity in pharmaceutical research.

Conclusion

Kiran K Jadhav's contributions to pharmaceutical compositions exemplify his commitment to improving drug delivery systems. His innovative patents and collaborative efforts position him as a key figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…